Howcroft T Kevin, Weissman Jocelyn D, Gegonne Anne, Singer Dinah S
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
J Immunol. 2005 Feb 15;174(4):2106-15. doi: 10.4049/jimmunol.174.4.2106.
MHC class I expression is subject to both tissue-specific and hormonal regulatory mechanisms. Consequently, levels of expression vary widely among tissues, with the highest levels of class I occurring in the lymphoid compartment, in T cells and B cells. Although the high class I expression in B cells is known to involve the B cell enhanceosome, the molecular basis for high constitutive class I expression in T cells has not been explored. T cell-specific genes, such as TCR genes, are regulated by a T cell enhanceosome consisting of RUNX1, CBFbeta, LEF1, and Aly. In this report, we demonstrate that MHC class I gene expression is enhanced by the T cell enhanceosome and results from a direct interaction of the RUNX1-containing complex with the class I gene in vivo. T cell enhanceosome activation of class I transcription is synergistic with CIITA-mediated activation and targets response elements distinct from those targeted by CIITA. These findings provide a molecular basis for the high levels of MHC class I in T cells.
MHC I类分子的表达受组织特异性和激素调节机制的影响。因此,其表达水平在不同组织间差异很大,在淋巴系统、T细胞和B细胞中I类分子的表达水平最高。虽然已知B细胞中I类分子的高表达涉及B细胞增强体,但T细胞中I类分子组成型高表达的分子基础尚未得到探索。T细胞特异性基因,如TCR基因,受由RUNX1、CBFβ、LEF1和Aly组成的T细胞增强体调控。在本报告中,我们证明MHC I类基因的表达被T细胞增强体增强,并且是由含RUNX1的复合物在体内与I类基因直接相互作用所致。I类转录的T细胞增强体激活与CIITA介导的激活具有协同作用,且靶向不同于CIITA所靶向的反应元件。这些发现为T细胞中高水平的MHC I类分子提供了分子基础。